Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.36B |
| 2 |
AT&T
T
|
+$117M |
| 3 |
PayPal
PYPL
|
+$95.6M |
| 4 |
eBay
EBAY
|
+$95.2M |
| 5 |
Adobe
ADBE
|
+$94.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$198M |
| 2 |
Walmart Inc
WMT
|
+$179M |
| 3 |
NVIDIA
NVDA
|
+$173M |
| 4 |
Johnson & Johnson
JNJ
|
+$144M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.76% |
| 2 | Healthcare | 9.26% |
| 3 | Consumer Discretionary | 9.01% |
| 4 | Financials | 8.43% |
| 5 | Communication Services | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Telus
TU
$15.3B
| $252K | ﹤0.01% |
18,562
-775
| -4% | -$12K |
|
652
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.92B
| $248K | ﹤0.01% |
2,598
-528
| -17% | -$51K |
|
653
Papa John's
PZZA
$806M
| $246K | ﹤0.01% |
5,998
-14,956
| -71% | -$735K |
|
654
Hewlett Packard
HPE
$70.5B
| $246K | ﹤0.01% |
11,509
-20,015
| -63% | -$423K |
|
655
Certara
CERT
$1.25B
| $245K | ﹤0.01% |
23,034
-55,782
| -71% | -$606K |
|
656
BlackLine
BL
$1.72B
| $244K | ﹤0.01% |
+4,018
| New | +$240K |
|
657
Coursera
COUR
$1.54B
| $243K | ﹤0.01% |
28,548
-68,912
| -71% | -$532K |
|
658
Privia Health
PRVA
$2.87B
| $241K | ﹤0.01% |
12,318
-28,797
| -70% | -$571K |
|
659
Pentair
PNR
$11B
| $239K | ﹤0.01% |
+2,377
| New | +$244K |
|
660
Evolent Health
EVH
$447M
| $238K | ﹤0.01% |
21,118
-51,380
| -71% | -$903K |
|
661
NeoGenomics
NEO
$2.13B
| $237K | ﹤0.01% |
14,397
-35,957
| -71% | -$558K |
|
662
Ulta Beauty
ULTA
$24.3B
| $237K | ﹤0.01% |
545
-31,770
| -98% | -$12.3M |
|
663
ACI Worldwide
ACIW
$5.42B
| $237K | ﹤0.01% |
4,560
-12,829
| -74% | -$682K |
|
664
ArcBest
ARCB
$3.08B
| $229K | ﹤0.01% |
+2,449
| New | +$259K |
|
665
Phreesia
PHR
$773M
| $226K | ﹤0.01% |
8,971
-21,474
| -71% | -$459K |
|
666
Doximity
DOCS
$4.88B
| $225K | ﹤0.01% |
4,222
-753
| -15% | -$36.9K |
|
667
Evertec
EVTC
$1.78B
| $223K | ﹤0.01% |
6,459
-61,410
| -90% | -$2.11M |
|
668
Omnicell
OMCL
$1.68B
| $221K | ﹤0.01% |
4,959
-12,970
| -72% | -$583K |
|
669
Iron Mountain
IRM
$36.1B
| $218K | ﹤0.01% |
+2,074
| New | +$244K |
|
670
LeMaitre Vascular
LMAT
$1.86B
| $217K | ﹤0.01% |
2,353
-5,730
| -71% | -$551K |
|
671
Transmedics
TMDX
$2.91B
| $216K | ﹤0.01% |
3,463
-1,409
| -29% | -$131K |
|
672
Air Products & Chemicals
APD
$67.6B
| $213K | ﹤0.01% |
735
-234
| -24% | -$73.5K |
|
673
Saic
SAIC
$5.35B
| $212K | ﹤0.01% |
1,897
-6,432
| -77% | -$849K |
|
674
Weis Markets
WMK
$1.86B
| $212K | ﹤0.01% |
3,125
-7,184
| -70% | -$494K |
|
675
Worthington Enterprises
WOR
$2.86B
| $209K | ﹤0.01% |
5,214
-14,076
| -73% | -$570K |
|
Similar funds
Ray Dalio's Q4 2024 Portfolio in Review
As of Q4 2024, Ray Dalio held 855 positions worth $21.8B, up 24% from $17.7B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Ray Dalio deployed $4.28B of net new capital in Q4 2024, opening 82 new positions and adding to 262 existing holdings. Its largest new stake was ServiceNow: 281,970 shares worth $59.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Procter & Gamble, an estimated $198M trimmed.
- Ray Dalio's largest Q4 2024 buy was ServiceNow: 281,970 shares worth $59.8M.
- Ray Dalio added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $4.36B increase.
- Ray Dalio's biggest Q4 2024 reduction was Procter & Gamble, cutting an estimated $198M.
- Ray Dalio fully exited Micron Technology in Q4 2024, selling an estimated $102M.
- Ray Dalio's ten largest holdings make up 43% of its $21.8B portfolio in Q4 2024.
- Ray Dalio opened 82 new positions and closed 164 in Q4 2024.
- Ray Dalio's portfolio value rose 24% quarter-over-quarter to $21.8B.
Based on Bridgewater Associates's 13F filing for Q4 2024, filed 13 Feb 2025.